Potential Use of CTCs as Biomarkers in Renal Cancer Patients

We demonstrated that the CellCollector is an appropriate tool for detecting CTCs in RCC patients. We examined EpCAM and MUC1 expression levels in RCC tissues and cell lines and analyzed the detection rate of CTCs in blood samples ex vivo using an anti-EpCAM antibody-covered straight or spiraled Cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Bialek, Joanna, Wencker, Andreas, Kawan, Felix, Yankulov, Stefan, Fornara, Paolo, Theil, Gerit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779819/
https://www.ncbi.nlm.nih.gov/pubmed/35054482
http://dx.doi.org/10.3390/life12010089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779819/
https://www.ncbi.nlm.nih.gov/pubmed/35054482
http://dx.doi.org/10.3390/life12010089

Ejemplares similares